Speakers also stressed the importance of a successful US-China Presidential Summit this week in Beijing in providing greater stability and predictability for business planning, while warning that prolonged tensions could undermine the competitiveness of American firms in key sectors ranging from manufacturing to pharmaceuticals.
The remainder of the day’s program examined the political, economic, and strategic dimensions shaping the future of the US-China relationship. In keynote conversations, House Select Committee Chairman John Moolenaar and House Foreign Affairs Committee Chairman Brian Mast discussed the growing bipartisan focus in Washington on strategic competition with China, including the implications for trade, technology, supply chains, and national security policy.
Panels throughout the afternoon explored China’s domestic political trajectory under Xi Jinping, the outlook for the Chinese economy amid slowing growth and strong exports, and the evolution of Beijing’s industrial policies through the upcoming 15th Five-Year Plan and “Made in China 2030.” Discussions also examined sector-specific competition in areas including biotechnology, AI, electric vehicles, and advanced manufacturing, as well as the strategic and economic risks associated with both action and inaction in managing the US-China relationship.